Moderna stock has fallen over the past four years, but shares got a boost on positive comments about AI. Is MRNA stock a buy ...

Moderna Inc (MRNA) stock saw a modest uptick, ending the day at $38.5 which represents a slight increase of $2.61 or 7.27% from the prior close of $35.89. The stock opened at $36.35 and touched a low ...

In an effort to combat the growing threat of monkeypox (mpox), scientists from Türkiye and the United Kingdom have joined ...

Oracle founder Larry Ellison said the Stargate project, a joint venture with OpenAI and Softbank, will help to fuel the ...

President Donald Trump announced a $500billion investment for private companies to develop artificial intelligence tools to ...

Oracle chairman Larry Ellison has announced that AI will soon develop customised mRNA vaccine against cancer for every individual within 48 hours.

We rate BioNTech SE a hold due to volatile performance, weak growth, and premium valuation amidst COVID-19 vaccine reliance.

No person-to-person spread has been detected, but that doesn’t mean an H5N1 avian influenza pandemic isn’t possible or even ...

New research reveals that sunburn’s acute effects, like inflammation and cell death, are triggered by RNA damage rather than ...

University of Wisconsin–Madison researchers have developed a promising technique for treating osteoarthritis using ...

People genetically susceptible to Huntington's disease often see their movement, mood, and cognition decline slowly over time.

We're learning more about a massive artificial intelligence infrastructure bill announced Tuesday by President Donald Trump.